Intercure Ltd. Logo

Intercure Ltd.

Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.

INCR | TA

Overview

Corporate Details

ISIN(s):
IL0011063760
LEI:
549300KI5ESXF8F5GP06
Country:
Israel
Address:
11 USSISHKIN STREET, 3844346 HADERA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Intercure Ltd. is a pharmaceutical company focused on the medical cannabis sector. Its operations span research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis-based products. Operating under the brand name Canndoc, the company is recognized as a leading, profitable, and rapidly growing cannabis enterprise outside of North America. Intercure is dedicated to developing and providing high-quality, standardized cannabis products for medical use to patients and pharmacies globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 18:49
Foreign Filer Report
Immediate Report
English 473.8 KB
2025-09-19 18:49
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-05-02 16:15
Foreign Filer Report
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
English 203.6 KB
2025-05-02 16:15
Foreign Filer Report
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
English 36.2 KB
2025-05-01 16:08
Foreign Filer Report
FORM 20-F
English 1.9 MB
2025-05-01 16:08
Foreign Filer Report
FORM 20-F
English 36.3 KB
2025-02-13 09:09
Foreign Filer Report
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
English 147.7 KB
2025-02-13 09:09
Foreign Filer Report
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
English 36.3 KB
2025-02-04 00:14
Foreign Filer Report
Results of an Extraordinary General Meeting held on February 3, 2025
English 120.2 KB
2025-02-04 00:14
Foreign Filer Report
Results of an Extraordinary General Meeting held on February 3, 2025
English 36.3 KB
2025-02-02 09:30
Pre-Annual General Meeting Information
A meeting to be held on February 3, 2025-Amendment regarding the private placem…
English 215.3 KB
2025-02-02 09:30
Foreign Filer Report
A meeting to be held on February 3, 2025-Amendment regarding the private placem…
English 36.3 KB
2025-01-28 00:20
Foreign Filer Report
The Extraordinary General Meeting was adjourned to February 3, 2025 due to lack…
English 121.9 KB
2025-01-28 00:20
Foreign Filer Report
The Extraordinary General Meeting was adjourned to February 3, 2025 due to lack…
English 36.2 KB
2024-12-31 00:54
Foreign Filer Report
Results of an Annual General Meeting of Shareholders held On December 30, 2024
English 119.9 KB

Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Intercure Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.